Philippines approves emergency use of J&J, Bharat Biotech COVID-19 vaccines

Published: Updated:
Enable Read mode
100% Font Size

The Philippines’ Food and Drug Administration (FDA) has allowed the emergency use of COVID-19 vaccines made by Johnson & Johnson and India’s Bharat Biotech, it said on Tuesday.

Both vaccines can be administered to people aged 18 and above in the Philippines, the agency chief, Rolando Enrique Domingo, said in a mobile text message.


For more coronavirus news, visit our dedicated page.

The single-shot coronavirus vaccines developed by J&J’s unit Janssen and Bharat Biotech’s Covaxin are the fifth and sixth to receive emergency use approval in the Philippines, which is battling one of the worst outbreaks in Asia.

J&J is conducting late-stage clinical trials for its COVID-19 vaccine in the Philippines.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

Philippines suspends use of AstraZeneca vaccine for people under 60

Philippines extends COVID-19 lockdown in economic hub

Britain adds four more countries to COVID-19 travel ‘red list’

Top Content Trending